Jain Vivek's Form 4 filing
Icu Medical Inc (ICUI) · filed Mar 4, 2022
- Accession no.
- 0001410442-22-000001
- Filed
- Mar 4, 2022
- Trade date
- Mar 3, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.64M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jain VivekCIK 0001410442 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | MOption exerciseAcquired | +36,000 | $58.79 | +$2,116,440 | 48,779 | Direct | |
| Mar 3, 2022 | Common Stock | SSaleDisposed | −36,000 | $240.00F2 | −$8,640,000 | 12,779 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | MOption exerciseDisposed | −36,000 | $0.00 | $0 | 206,366 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
All shares sold were sold at the exact price disclosed.
Referenced by the price of 1 transaction in Table I.